🕒 Wednesday 19 August 2026 Wed, 19 Aug 2026

Shriro Holdings (ASX: SHM) posted a 7.5% revenue increase to $111 million for FY26, alongside a 44% jump in net profit after tax to $10.8 million. The company declared a fully franked final dividend and completed substantial share buy-backs, while guiding FY27 EBITDA to $12–15 million amid increased marketing spend.

Telstra Group Limited has updated the calculation period for the reinvestment price of its Dividend Reinvestment Plan (DRP) linked to the six-month dividend ending June 2026. The interim dividend remains at AUD 0.105 per share, mostly franked, with no discount on DRP shares.

Yowie Group's revenue declined in the first half of 2026 as it navigated supply chain shifts and cautious retail demand, but the company secured a significant Australian licensing deal and ended costly legacy litigation.

H2G Limited trims its half-year loss by a third while advancing sodium-ion battery production and securing a $4.5 million sales pipeline. Strategic partnerships and government certification efforts aim to boost market adoption.

Loyal Metals (ASX:LLM) schedules a key court hearing on 24 August to approve PT Bumi Resources’ A$79 million takeover scheme, with most conditions including shareholder approval and project acquisitions progressing smoothly.

Audalia Resources has raised $450,000 through a placement of 15 million shares at 3 cents each, aiming to push the Medcalf project towards production while maintaining working capital.

Energy Fuels Inc. reported a transformative 2024 with a major acquisition boosting its heavy mineral sands assets, a uranium production ramp-up at key US mines, and commercial rare earth oxide output from its White Mesa Mill.

InvestSMART Group Limited swung to a net loss of $575,633 in FY26, marking a sharp reversal from the prior year’s profit, amid a strategic pivot including a pending $16 million sale of its Intelligent Investor business.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.

Australis Oil & Gas Ltd posted a $2.6 million net loss for 1H 2026 amid sharply reduced production volumes but is progressing its Tuscaloosa Marine Shale development with a key partner and a planned Q4 well spud.

Synertec Corporation has been awarded the delivery phase of the Brooklyn Pump Station IO Upgrade by Melbourne Water, extending a contract valued at approximately $1.1 million. The project modernises critical water infrastructure with advanced operational technology.

MA Credit Income Trust (ASX: MA1) launches a voluntary off-market buy-back for up to 2.5% of units at net asset value, aiming to provide liquidity and capital management benefits to unitholders.

Ironbark Balanced Income Limited reported a 5.6% decline in net profit to $2.89 million for FY2026, while its investment portfolio delivered a solid 7.8% return, outperforming its benchmark and maintaining fully franked dividends.

Energy Fuels’ acquisition of Australian Strategic Materials (ASM) has officially closed following Federal Court approval, triggering suspension of ASM trading and setting the stage for shareholder payments and new listings.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

Recce Pharmaceuticals has secured ethics approval to add an active-controlled arm to its pivotal Phase 3 trial of RECCE® 327 Topical Gel for diabetic foot infections in Australia, enabling head-to-head comparison against existing antibiotics.

Seeka Ltd (NZX:SEK) has announced a fully imputed dividend of 20 cents per share, payable in October, alongside a reinstatement of its biannual dividend schedule. The dividend reinvestment plan offers a 2% discount on shares acquired via the plan.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

Canadian Phosphate Limited’s initial 2026 drilling at Wapiti has successfully intersected phosphate mineralisation in all eight holes, extending the known Main Zone strike by over 3km. Assay results are pending, with a resource update planned for late 2026.

Magnum Mining has completed nearly 7,000m of drilling at its Piracanjuba North rare earth project, expanding its footprint ahead of a planned November resource estimate, while assay results from Palmares await interpretation amid a strategic portfolio review.

ACDC Metals is set to launch its maiden drilling campaign at the Mount Jackson Project in Nevada, targeting key gold-silver zones with a 2,500-metre reverse circulation program starting in Q4 2026. A geophysical survey will precede drilling to sharpen targets and reduce costs.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.